LDN-27219 | m-entrepreneurship.com

Product Name :
LDN-27219

Search keywords :
LDN-27219

drugId :
null

Target Vo:
Protein-glutamine gamma-glutamyltransferase

Target Vo Short Name :
TGM2

Moa_Name:
Protein-glutamine gamma-glutamyltransferase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Harvard University

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Nerve Degeneration

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Duvortuxizumab References
AMPK alpha 1 Rabbit mAb MedChemExpress
FSP1 Antibody: FSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to FSP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Monkey.

Author: Betaine hydrochloride

Related Posts